HHS Inspector General Investigating Drug Savings For Medicare In FY 2014 Work Plan
OIG is examining how Medicare could benefit if it shared in the drug discounts available through the 340B program, the potential impact of changes to Part B ASP reporting and other Medicare and Medicaid drug-related topics during this and the coming fiscal year.
You may also be interested in...
Public Citizen asks whether CMS policy could have helped prevent the drug contamination at New England Compounding Center as Senate committee wants more information on states’ regulatory practices.
A number of topical issues will be investigated by the HHS Office of Inspector General, according to its work plan for fiscal year 2013. Pharma industry issues are concentrated in the Medicare and Medicaid space.
Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.